US 11753474
Anti-Dectin-2 antibodies
granted A61PA61P35/00
Quick answer
US patent 11753474 (Anti-Dectin-2 antibodies) held by Bolt Biotherapeutics, Inc. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bolt Biotherapeutics, Inc.
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 131
- CPC classes
- A61P, A61P35/00